COMPANY PROFILE / #714
Alltrna
Developer of a tRNA-based therapeutic platform intended to harness and engineer transfer RNAs to correct genetic defects and treat a wide range of diseases. The company's platform incorporates artificial intelligence and machine learning tools to learn the tRNA language and deliver diverse, programmable molecules with broad therapeutic potential, enabling researchers developing genetic medicines to restore functional protein production across diverse disease types.Privately Held (backing)
已融资52
最新估值—
员工数—
成立年份WaVe Life Sciences, Homology Medicines, Jounce Therapeutics, Verge Analytics, eTheRNA, MicroCures, Tmunity, Minoryx, Eligo Bioscience, Tevard Biosciences, Strand Therapeutics, Editas Medicine, CRISPR Therapeutics, Casma Therapeutics, AskBio, Intellia Therapeutics, ShapeTX, Precision BioSciences, aTyr Pharma, AlloVir, Korro Bio, Dimension Therapeutics, Spotlight Therapeutics, Second Genome, NexImmune, AavantiBio, Aqualung Therapeutics, iBio, Poseida Therapeutics, Amunix Pharmaceuticals, CureVac, Praxis (Drug Discovery), Cellectis, Repare Therapeutics, Beam Therapeutics, MicroBiome Therapeutics, Mitochon Pharmaceuticals, Enterprise Therapeutics, Zymeworks, Regenxbio, Intarcia, ReViral, Voyager Therapeutics, Sangamo Therapeutics, Galectin Therapeutics, Windtree Therapeutics, Anaeropharma Science, Promedior, ReCode Therapeutics, Solid Biosciences, FibroGen (China), Pliant Therapeutics, Merus, Alector, Sarepta Therapeutics, Genetix Biotherapeutics, Breath Therapeutics, Aruvant, Aptuit, True North Therapeutics, Seres Therapeutics, Translate Bio, Fulcrum Therapeutics, Xencor, Minerva Neurosciences, Genentech, Taxon Biosciences, Allogene Therapeutics, Locanabio, Arcturus Therapeutics Holdings, Aceragen, Adverum Biotechnologies, Vertex Pharmaceuticals, Eloxx Pharmaceuticals, AVROBIO, ReveraGen BioPharma, Lung Therapeutics, ToolGen, Exonate, Vtesse, AveXis, Affimed, Alnylam Pharmaceuticals, Regulus Therapeutics, ElevateBio, Kadmon Holdings, Abeona Therapeutics, Verona Pharma, Axsome Therapeutics, Aura Biosciences, Kyntra Bio, Spark Therapeutics, Caribou Biosciences, BioMarin Pharmaceutical, Dicerna Pharmaceuticals, Axolabs, Avidity Biosciences, ApoCell, Marinus Pharmaceuticals, SAGE Therapeutics, Arrowhead Pharmaceuticals, Pulmatrix, Lakefront Biotherapeutics, Intas Pharmaceuticals, MiRXES
公司概况
- Companies
- Alltrna
- Description
- —
- Website
- Cambridge, MA
- HQ Location
- Developer of a tRNA-based therapeutic platform intended to harness and engineer transfer RNAs to correct genetic defects and treat a wide range of diseases. The company's platform incorporates artificial intelligence and machine learning tools to learn the tRNA language and deliver diverse, programmable molecules with broad therapeutic potential, enabling researchers developing genetic medicines to restore functional protein production across diverse disease types.
- Year Founded
- WaVe Life Sciences, Homology Medicines, Jounce Therapeutics, Verge Analytics, eTheRNA, MicroCures, Tmunity, Minoryx, Eligo Bioscience, Tevard Biosciences, Strand Therapeutics, Editas Medicine, CRISPR Therapeutics, Casma Therapeutics, AskBio, Intellia Therapeutics, ShapeTX, Precision BioSciences, aTyr Pharma, AlloVir, Korro Bio, Dimension Therapeutics, Spotlight Therapeutics, Second Genome, NexImmune, AavantiBio, Aqualung Therapeutics, iBio, Poseida Therapeutics, Amunix Pharmaceuticals, CureVac, Praxis (Drug Discovery), Cellectis, Repare Therapeutics, Beam Therapeutics, MicroBiome Therapeutics, Mitochon Pharmaceuticals, Enterprise Therapeutics, Zymeworks, Regenxbio, Intarcia, ReViral, Voyager Therapeutics, Sangamo Therapeutics, Galectin Therapeutics, Windtree Therapeutics, Anaeropharma Science, Promedior, ReCode Therapeutics, Solid Biosciences, FibroGen (China), Pliant Therapeutics, Merus, Alector, Sarepta Therapeutics, Genetix Biotherapeutics, Breath Therapeutics, Aruvant, Aptuit, True North Therapeutics, Seres Therapeutics, Translate Bio, Fulcrum Therapeutics, Xencor, Minerva Neurosciences, Genentech, Taxon Biosciences, Allogene Therapeutics, Locanabio, Arcturus Therapeutics Holdings, Aceragen, Adverum Biotechnologies, Vertex Pharmaceuticals, Eloxx Pharmaceuticals, AVROBIO, ReveraGen BioPharma, Lung Therapeutics, ToolGen, Exonate, Vtesse, AveXis, Affimed, Alnylam Pharmaceuticals, Regulus Therapeutics, ElevateBio, Kadmon Holdings, Abeona Therapeutics, Verona Pharma, Axsome Therapeutics, Aura Biosciences, Kyntra Bio, Spark Therapeutics, Caribou Biosciences, BioMarin Pharmaceutical, Dicerna Pharmaceuticals, Axolabs, Avidity Biosciences, ApoCell, Marinus Pharmaceuticals, SAGE Therapeutics, Arrowhead Pharmaceuticals, Pulmatrix, Lakefront Biotherapeutics, Intas Pharmaceuticals, MiRXES
- Keywords
- 2023: 52, 2022: 38, 2021: 30
- Competitors
- —
- Ownership Status
- —
- Company Financing Status
- Privately Held (backing)
融资与估值
- Total Raised
- 52
- First Financing Date
- 89.50
- First Financing Size
- 3
- First Financing Valuation
- lafzelius@metaphorebio.com
- Last Financing Date
- -1.39%
- Last Financing Deal Type
- 09-Aug-2023
- Last Financing Size
- Later Stage VC
- Last Financing Valuation
- —
- Last Financing Status
- 509.00
- Last Known Valuation
- —
- Last Known Valuation Date
- Later Stage VC
- Last Known Valuation Deal Type
- 35.00
- Valuation Estimate
- 09-Aug-2023
- Valuation Estimate Growth Rate
- biology test, drug research company, gene therapy, genetic research, medicine data, molecules detection, researchers database, therapeutic model, trna therapy
- Active Investors
- Venture Capital-Backed
- # Active Investors
- —
- Acquirers
- Flagship Pioneering
团队与联系人
- Employees
- —
- Employee Growth %
- 2018
- Employee History
- —
- Primary Contact
- 144.00
- Primary Contact Title
- —
- Primary Contact Email
- Lovisa Afzelius
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- 37.10%
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- 186
- Size Multiple
- —
- Size Multiple % Change
- 509.00
- Size Multiple Change
- 0.00%
- Size Multiple Percentile
- 0.00x
- Majestic Referring Domains
- 7.15x
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- 09-Nov-2021
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- 0
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- Board Member, Chairperson & Founding Chief Executive Officer
记录来源：public.companies · 原始序号 #714 · 所有字段均按数据库原值展示。